As of 2024-12-13, the Intrinsic Value of Meridian Bioscience Inc (VIVO) is
32.73 USD. This VIVO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 33.97 USD, the upside of Meridian Bioscience Inc is
-3.70%.
The range of the Intrinsic Value is 23.39 - 57.70 USD
32.73 USD
Intrinsic Value
VIVO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
23.39 - 57.70 |
32.73 |
-3.7% |
| DCF (Growth 10y) |
26.18 - 60.65 |
35.65 |
5.0% |
| DCF (EBITDA 5y) |
23.00 - 32.50 |
27.59 |
-18.8% |
| DCF (EBITDA 10y) |
26.63 - 38.63 |
32.18 |
-5.3% |
| Fair Value |
22.40 - 22.40 |
22.40 |
-34.07% |
| P/E |
36.62 - 48.53 |
42.19 |
24.2% |
| EV/EBITDA |
24.14 - 33.57 |
28.39 |
-16.4% |
| EPV |
16.46 - 21.29 |
18.87 |
-44.4% |
| DDM - Stable |
9.41 - 32.01 |
20.71 |
-39.0% |
| DDM - Multi |
16.59 - 44.74 |
24.31 |
-28.4% |
VIVO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,494.96 |
| Beta |
0.23 |
| Outstanding shares (mil) |
44.01 |
| Enterprise Value (mil) |
1,438.51 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.94% |
| Cost of Debt |
4.25% |
| WACC |
8.85% |